Effect of Curcumin on Experimental Models of Cystic Fibrosis: A Systematic Review
Open Access
- 10 May 2022
- journal article
- review article
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 32 (2)
Abstract
Context: Cystic fibrosis (CF) is a genetic disorder characterized by CF transmembrane conductance regulator (CFTR) gene defects and chronic inflammation. Management of CF patients is challenging, and no definitive treatment is available. Although evidence suggests that curcumin is effective against inflammation and can regulate ion channels, its effect on CF patients is not well established. Objectives: This systematic review evaluated the available evidence for the application of curcumin in experimental models of CF. Evidence Acquisition: The data in this study were selected from articles published in PubMed, ScienceDirect, ProQuest, and Springer until July 2021. Articles on the use of curcumin in CF patients were included based on the purpose of the study. In this review, 11 articles were found in the final search. Then, a quality assessment was performed using SYRCLE’s RoB tool. Results: Eleven out of 2188 screened studies were eligible for this systematic review. Most in vitro studies (7 out of 8) reported that curcumin influences channel function through a variety of mechanisms, while only 1 study provided comparable results. Regarding anti-inflammatory function, 1 study showed that curcumin could suppress the toll-like receptor 2 (TLR2) gene and protein expression in the CF bronchial epithelial cell line. Two of 3 in vivo studies reported channel correction with curcumin. Conclusions: The available evidence in this systematic study demonstrates the usefulness of curcumin via different mechanisms among different study models. Given that few studies have been conducted in this field, this systematic review suggests more investigations be undertaken to facilitate generalization to human studies.Keywords
This publication has 26 references indexed in Scilit:
- Discovery of curcumin, a component of golden spice, and its miraculous biological activitiesClinical and Experimental Pharmacology and Physiology, 2011
- Partial Correction of Cystic Fibrosis Defects with PLGA Nanoparticles Encapsulating CurcuminMolecular Pharmaceutics, 2009
- Curcumin Cross-links Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Polypeptides and Potentiates CFTR Channel Activity by Distinct MechanismsJournal of Biological Chemistry, 2009
- The Use of Complementary and Alternative Medicine Among Pediatric Cystic Fibrosis PatientsThe Journal of Alternative and Complementary Medicine, 2008
- Curcumin enhances cystic fibrosis transmembrane regulator expression by down-regulating calreticulinBiochemical and Biophysical Research Communications, 2007
- The Use of Complementary and Alternative Medicine in Children with Chronic Medical ConditionsAmerican Journal of Physical Medicine & Rehabilitation, 2006
- Rescue of ΔF508-CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) by Curcumin: Involvement of the Keratin 18 NetworkThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Some like it hot: curcumin and CFTRTrends in Molecular Medicine, 2004
- Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cellsBiochemical and Biophysical Research Communications, 2004
- Evidence against the Rescue of Defective ΔF508-CFTR Cellular Processing by Curcumin in Cell Culture and Mouse ModelsJournal of Biological Chemistry, 2004